SCHEMBL6258769

SCHEMBL6258769

CCCc1cccc2c1C(=O)N(C(CCC(=O)O)C(N)=O)C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
POLB P06746 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 2/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX12 P18054 1/20 0.51
NFKB1 P19838 1/20 0.51
APEX1 P27695 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6260150 0.93 ALDH1A1 (0.49) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL6259576 0.92 ALDH1A1 (0.54) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL6262410 0.88 POLB (0.46) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL6259531 0.86 KMT2A (0.54) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL6259464 0.84 ALDH1A1 (0.57) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL6271191 0.84 ALDH1A1 (0.54) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL2282787 0.83 KDM4E (0.58) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL476926 0.83 KDM4E (0.58) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL20294664 0.82 ALDH1A1 (0.57) ALDH1A1POLBKDM4EHPGDMAPK1
SCHEMBL20294662 0.82 ALDH1A1 (0.57) ALDH1A1POLBKDM4EHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163219-B1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORP (US) 2005-10-12 EP disclosed
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
CN-1342146-A Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels CELGENE CORP (US) 2002-03-27 CN disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed